Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $270,768 | 166 | 67.9% |
| Travel and Lodging | $51,203 | 118 | 12.8% |
| Consulting Fee | $49,800 | 47 | 12.5% |
| Food and Beverage | $25,556 | 360 | 6.4% |
| Unspecified | $1,154 | 4 | 0.3% |
| Education | $100.57 | 5 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $156,701 | 171 | $0 (2024) |
| United Therapeutics Corporation | $101,344 | 124 | $0 (2024) |
| Abbott Laboratories | $67,388 | 282 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $35,560 | 23 | $0 (2022) |
| Medtronic Vascular, Inc. | $16,111 | 49 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $11,900 | 3 | $0 (2023) |
| CVRx, Inc. | $4,187 | 16 | $0 (2024) |
| Medtronic, Inc. | $2,547 | 5 | $0 (2023) |
| Actelion Pharmaceuticals, Ltd | $799.00 | 1 | $0 (2021) |
| ABIOMED | $333.27 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,534 | 67 | Actelion Pharmaceuticals US, Inc. ($23,815) |
| 2023 | $42,331 | 67 | Actelion Pharmaceuticals US, Inc. ($23,107) |
| 2022 | $46,145 | 60 | Actelion Pharmaceuticals US, Inc. ($15,129) |
| 2021 | $31,621 | 37 | United Therapeutics Corporation ($15,154) |
| 2020 | $25,755 | 35 | United Therapeutics Corporation ($7,983) |
| 2019 | $63,113 | 100 | United Therapeutics Corporation ($23,032) |
| 2018 | $91,373 | 183 | Actelion Pharmaceuticals US, Inc. ($35,148) |
| 2017 | $62,712 | 151 | Actelion Pharmaceuticals US, Inc. ($28,287) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: Heart Failure | ||||||
| 12/24/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: Heart Failure | ||||||
| 12/10/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $183.41 | General |
| Category: Cardiovascular Device | ||||||
| 12/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $1,365.63 | General |
| Category: Heart Failure | ||||||
| 12/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| Category: Heart Failure | ||||||
| 12/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| Category: Heart Failure | ||||||
| 12/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $67.23 | General |
| Category: Heart Failure | ||||||
| 12/03/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $638.95 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,090.00 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | United Therapeutics Corporation | — | Food and Beverage | Cash or cash equivalent | $116.71 | General |
| 10/25/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $54.68 | General |
| Category: Heart Failure | ||||||
| 10/23/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $420.64 | General |
| Category: Heart Failure | ||||||
| 10/23/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Travel and Lodging | In-kind items and services | $62.99 | General |
| Category: Heart Failure | ||||||
| 10/16/2024 | United Therapeutics Corporation | TYVASO (Drug), ORENITRAM, REMODULIN | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,090.00 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,815.00 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $712.12 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $545.00 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | AngioDynamics, Inc. | ANGIOVAC (Device) | Food and Beverage | In-kind items and services | $105.77 | General |
| Category: VIT | ||||||
| 08/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $114.77 | General |
| Category: Heart Failure | ||||||
| 08/30/2024 | AngioDynamics, Inc. | ANGIOVAC (Device) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: VIT | ||||||
| 08/15/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,090.00 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $73.22 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AN OPEN-LABEL EXTENSION STUDY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION HFPEF - A LONG-TERM FOLLOW-UP TO STUDY TDE-HF-301 | United Therapeutics Corporation | $1,154 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 937 | 1,392 | $388,410 | $98,150 |
| 2022 | 21 | 924 | 1,287 | $367,620 | $88,997 |
| 2021 | 22 | 920 | 1,274 | $370,586 | $96,775 |
| 2020 | 25 | 1,136 | 1,567 | $434,722 | $101,745 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 129 | 177 | $40,710 | $20,800 | 51.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 111 | $65,490 | $17,780 | 27.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 141 | $28,200 | $12,631 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 111 | $18,870 | $8,800 | 46.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $15,180 | $6,618 | 43.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 127 | 127 | $60,642 | $5,821 | 9.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 45 | 48 | $68,160 | $4,096 | 6.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 28 | $8,960 | $3,709 | 41.4% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 25 | 114 | $9,918 | $3,378 | 34.1% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 15 | 83 | $10,126 | $3,155 | 31.2% |
| 93505 | Biopsy of heart muscle | Facility | 2023 | 12 | 16 | $14,080 | $2,304 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,590 | $1,899 | 41.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 19 | $4,655 | $1,656 | 35.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 17 | $2,550 | $1,146 | 44.9% |
| 93750 | Evaluation of lower heart chamber assist device | Office | 2023 | 11 | 23 | $2,001 | $863.65 | 43.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 38 | 46 | $6,210 | $841.72 | 13.6% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 49 | 58 | $4,582 | $594.42 | 13.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 53 | 61 | $7,381 | $546.40 | 7.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 22 | 23 | $4,025 | $537.18 | 13.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 21 | 21 | $1,785 | $490.60 | 27.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 34 | 42 | $3,990 | $218.00 | 5.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,305 | $151.48 | 11.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 42 | 50 | $5,000 | $112.80 | 2.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 122 | 171 | $39,330 | $21,152 | 53.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 72 | $42,480 | $11,633 | 27.4% |
About Dr. Ashwin Ravichandran, MD
Dr. Ashwin Ravichandran, MD is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1407012776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashwin Ravichandran, MD has received a total of $398,583 in payments from pharmaceutical and medical device companies, with $35,534 received in 2024. These payments were reported across 700 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($270,768).
As a Medicare-enrolled provider, Ravichandran has provided services to 3,917 Medicare beneficiaries, totaling 5,520 services with total Medicare billing of $385,667. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location Indianapolis, IN
- Active Since 08/05/2008
- Last Updated 08/10/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407012776
Products in Payments
- UPTRAVI (Drug) $87,573
- ORENITRAM (Drug) $38,971
- Adempas (Drug) $32,464
- REMODULIN (Drug) $24,567
- Circulatory Support (Device) $16,344
- OPSUMIT (Drug) $15,520
- NONE (Drug) $14,686
- HeartMate 3 Left Ventricular Dev (Device) $14,099
- HeartWare HVAD (Device) $13,252
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $12,612
- OPSUMIT MACITENTAN (Drug) $11,449
- CardioMEMS HF System (Device) $9,808
- CARDIOMEMS (Device) $8,413
- TYVASO (Drug) $6,405
- Barostim Neo System (Device) $4,187
- HeartMate (Device) $2,844
- HeartMate 3 Left Ventricular Assist Device (Device) $2,453
- Impella (Device) $333.27
- Mitra Clip system (Device) $320.76
- ENTRESTO (Drug) $271.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indianapolis
Rafat Abonour, Md, MD
Internal Medicine — Payments: $833,709
David Batt, Md, MD
Internal Medicine — Payments: $682,018
John Miller, Md, MD
Internal Medicine — Payments: $325,524
Naga Chalasani, Md, MD
Internal Medicine — Payments: $303,095
James Trippi, Md, MD
Internal Medicine — Payments: $280,481
Dr. Woodrow Corey, Md, MD
Internal Medicine — Payments: $262,512